Pressure BioSciences, Inc. (PBIO)
USD 0.0
(-66.17%)
USD 0.0
(-66.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 799.56 Thousand USD | 380.88% |
| 2022 | -284.66 Thousand USD | -126.86% |
| 2021 | 1.05 Million USD | 66.21% |
| 2020 | 637.73 Thousand USD | 4.05% |
| 2019 | 612.93 Thousand USD | -47.95% |
| 2018 | 1.17 Million USD | 21.76% |
| 2017 | 967.14 Thousand USD | -15.35% |
| 2016 | 1.14 Million USD | -3.88% |
| 2015 | 1.18 Million USD | 64.56% |
| 2014 | 722.3 Thousand USD | -22.79% |
| 2013 | 935.46 Thousand USD | 13.83% |
| 2012 | 821.8 Thousand USD | 27.44% |
| 2011 | 644.86 Thousand USD | -33.07% |
| 2010 | 963.51 Thousand USD | 14.35% |
| 2009 | 842.57 Thousand USD | 86.72% |
| 2008 | 451.24 Thousand USD | 3.3% |
| 2007 | 436.82 Thousand USD | 869.5% |
| 2006 | 45.05 Thousand USD | 162.73% |
| 2005 | -71.82 Thousand USD | 55.03% |
| 2004 | -159.7 Thousand USD | -101.89% |
| 2003 | 8.43 Million USD | -0.84% |
| 2002 | 8.5 Million USD | -2.34% |
| 2001 | 8.7 Million USD | 5.8% |
| 2000 | 8.22 Million USD | -33.65% |
| 1999 | 12.4 Million USD | 9.73% |
| 1998 | 11.3 Million USD | 10.78% |
| 1997 | 10.2 Million USD | 47.83% |
| 1996 | 6.9 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 115.94 Thousand USD | 647.8% |
| 2023 Q2 | 255.2 Thousand USD | -33.19% |
| 2023 Q4 | -21.16 Thousand USD | 90.78% |
| 2023 Q3 | -229.45 Thousand USD | -189.91% |
| 2023 FY | 799.56 Thousand USD | 380.88% |
| 2023 Q1 | 381.97 Thousand USD | 157.52% |
| 2022 FY | -284.66 Thousand USD | -126.86% |
| 2022 Q2 | 195.99 Thousand USD | 18.33% |
| 2022 Q3 | 17.82 Thousand USD | -90.9% |
| 2022 Q4 | -664.12 Thousand USD | -3824.96% |
| 2022 Q1 | 165.63 Thousand USD | 15.09% |
| 2021 FY | 1.05 Million USD | 66.21% |
| 2021 Q3 | 260.19 Thousand USD | -19.26% |
| 2021 Q1 | 333.59 Thousand USD | 140.19% |
| 2021 Q2 | 322.26 Thousand USD | -3.4% |
| 2021 Q4 | 143.92 Thousand USD | -44.69% |
| 2020 FY | 637.73 Thousand USD | 4.05% |
| 2020 Q1 | 78.72 Thousand USD | 551.13% |
| 2020 Q2 | 133.27 Thousand USD | 69.28% |
| 2020 Q3 | 286.84 Thousand USD | 115.24% |
| 2020 Q4 | 138.88 Thousand USD | -51.58% |
| 2019 Q2 | 214.49 Thousand USD | 6.96% |
| 2019 Q3 | 215.36 Thousand USD | 0.41% |
| 2019 Q4 | -17.45 Thousand USD | -108.1% |
| 2019 FY | 612.93 Thousand USD | -47.95% |
| 2019 Q1 | 200.52 Thousand USD | -14.83% |
| 2018 FY | 1.17 Million USD | 21.76% |
| 2018 Q4 | 235.44 Thousand USD | -18.09% |
| 2018 Q3 | 287.44 Thousand USD | -22.04% |
| 2018 Q2 | 368.72 Thousand USD | 28.93% |
| 2018 Q1 | 285.98 Thousand USD | 251.36% |
| 2017 Q2 | 253.07 Thousand USD | -19.75% |
| 2017 Q1 | 315.36 Thousand USD | 0.63% |
| 2017 FY | 967.14 Thousand USD | -15.35% |
| 2017 Q4 | 81.39 Thousand USD | -74.35% |
| 2017 Q3 | 317.31 Thousand USD | 25.39% |
| 2016 Q3 | 272.44 Thousand USD | 1.71% |
| 2016 FY | 1.14 Million USD | -3.88% |
| 2016 Q4 | 313.39 Thousand USD | 15.03% |
| 2016 Q1 | 288.77 Thousand USD | -12.71% |
| 2016 Q2 | 267.85 Thousand USD | -7.24% |
| 2015 Q1 | 249.35 Thousand USD | 151.17% |
| 2015 Q2 | 237.91 Thousand USD | -4.59% |
| 2015 FY | 1.18 Million USD | 64.56% |
| 2015 Q3 | 370.53 Thousand USD | 55.74% |
| 2015 Q4 | 330.84 Thousand USD | -10.71% |
| 2014 Q2 | 173.01 Thousand USD | -23.63% |
| 2014 Q4 | 99.27 Thousand USD | -55.58% |
| 2014 FY | 722.3 Thousand USD | -22.79% |
| 2014 Q1 | 226.54 Thousand USD | 50.43% |
| 2014 Q3 | 223.48 Thousand USD | 29.17% |
| 2013 Q4 | 150.59 Thousand USD | -38.48% |
| 2013 Q3 | 244.76 Thousand USD | -10.64% |
| 2013 FY | 935.46 Thousand USD | 13.83% |
| 2013 Q2 | 273.9 Thousand USD | 2.9% |
| 2013 Q1 | 266.19 Thousand USD | 178.14% |
| 2012 Q4 | 95.7 Thousand USD | -66.17% |
| 2012 Q2 | 215.7 Thousand USD | -5.17% |
| 2012 Q3 | 282.92 Thousand USD | 31.16% |
| 2012 Q1 | 227.46 Thousand USD | -6.76% |
| 2012 FY | 821.8 Thousand USD | 27.44% |
| 2011 Q3 | 186.81 Thousand USD | 66.22% |
| 2011 FY | 644.86 Thousand USD | -33.07% |
| 2011 Q4 | 243.94 Thousand USD | 30.58% |
| 2011 Q2 | 112.39 Thousand USD | 10.5% |
| 2011 Q1 | 101.71 Thousand USD | -48.85% |
| 2010 Q1 | 203.71 Thousand USD | -19.53% |
| 2010 FY | 963.51 Thousand USD | 14.35% |
| 2010 Q4 | 198.85 Thousand USD | -30.42% |
| 2010 Q3 | 285.81 Thousand USD | 3.88% |
| 2010 Q2 | 275.13 Thousand USD | 35.06% |
| 2009 Q4 | 253.15 Thousand USD | 4.04% |
| 2009 FY | 842.57 Thousand USD | 86.72% |
| 2009 Q1 | 166.51 Thousand USD | -16.92% |
| 2009 Q2 | 179.56 Thousand USD | 7.83% |
| 2009 Q3 | 243.33 Thousand USD | 35.52% |
| 2008 Q3 | 135.12 Thousand USD | 325.6% |
| 2008 Q2 | 31.75 Thousand USD | -62.17% |
| 2008 FY | 451.24 Thousand USD | 3.3% |
| 2008 Q1 | 83.92 Thousand USD | -13.1% |
| 2008 Q4 | 200.44 Thousand USD | 48.33% |
| 2007 FY | 436.82 Thousand USD | 869.5% |
| 2007 Q4 | 96.57 Thousand USD | 0.84% |
| 2007 Q2 | 144.49 Thousand USD | 44.55% |
| 2007 Q1 | 99.96 Thousand USD | 68.48% |
| 2007 Q3 | 95.77 Thousand USD | -33.72% |
| 2006 Q4 | 59.33 Thousand USD | 2629.3% |
| 2006 FY | 45.05 Thousand USD | 162.73% |
| 2006 Q2 | -18.32 Thousand USD | -1080.78% |
| 2006 Q1 | 1868.00 USD | 105.81% |
| 2006 Q3 | 2174.00 USD | 111.87% |
| 2005 Q4 | -32.15 Thousand USD | -44.69% |
| 2005 Q2 | -13.55 Thousand USD | -248.34% |
| 2005 Q1 | -3891.00 USD | 99.05% |
| 2005 FY | -71.82 Thousand USD | 55.03% |
| 2005 Q3 | -22.22 Thousand USD | -63.97% |
| 2004 FY | -159.7 Thousand USD | -101.89% |
| 2004 Q3 | 48.24 Thousand USD | -46.77% |
| 2004 Q2 | 90.63 Thousand USD | -95.83% |
| 2004 Q1 | 2.17 Million USD | 4.76% |
| 2004 Q4 | -409.02 Thousand USD | -947.78% |
| 2003 Q1 | 2.18 Million USD | -1.58% |
| 2003 FY | 8.43 Million USD | -0.84% |
| 2003 Q4 | 2.07 Million USD | 2.72% |
| 2003 Q3 | 2.02 Million USD | -5.76% |
| 2003 Q2 | 2.14 Million USD | -1.85% |
| 2002 Q2 | 2.37 Million USD | 26.18% |
| 2002 Q1 | 1.88 Million USD | -12.05% |
| 2002 FY | 8.5 Million USD | -2.34% |
| 2002 Q4 | 2.22 Million USD | 10.06% |
| 2002 Q3 | 2.01 Million USD | -15.14% |
| 2001 Q1 | 2.51 Million USD | 939.85% |
| 2001 Q4 | 2.14 Million USD | -2.7% |
| 2001 Q2 | 2.23 Million USD | -10.9% |
| 2001 Q3 | 2.2 Million USD | -1.61% |
| 2001 FY | 8.7 Million USD | 5.8% |
| 2000 FY | 8.22 Million USD | -33.65% |
| 2000 Q4 | -299.14 Thousand USD | -111.66% |
| 2000 Q3 | 2.56 Million USD | -22.37% |
| 2000 Q2 | 3.3 Million USD | 24.52% |
| 2000 Q1 | 2.65 Million USD | -14.36% |
| 1999 Q1 | 2.9 Million USD | -6.45% |
| 1999 Q2 | 2.9 Million USD | 0.0% |
| 1999 Q3 | 3.3 Million USD | 13.79% |
| 1999 FY | 12.4 Million USD | 9.73% |
| 1999 Q4 | 3.1 Million USD | -6.06% |
| 1998 Q4 | 3.1 Million USD | 14.81% |
| 1998 Q3 | 2.7 Million USD | -10.0% |
| 1998 Q2 | 3 Million USD | 20.0% |
| 1998 Q1 | 2.5 Million USD | -28.57% |
| 1998 FY | 11.3 Million USD | 10.78% |
| 1997 Q2 | 2 Million USD | -9.09% |
| 1997 Q1 | 2.2 Million USD | 0.0% |
| 1997 FY | 10.2 Million USD | 47.83% |
| 1997 Q4 | 3.5 Million USD | 29.63% |
| 1997 Q3 | 2.7 Million USD | 35.0% |
| 1996 Q4 | 2.2 Million USD | 22.22% |
| 1996 FY | 6.9 Million USD | 0.0% |
| 1996 Q3 | 1.8 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -71.437% |
| IR-Med Inc. | -17 Thousand USD | 4803.306% |
| Polarean Imaging plc | 335.48 Thousand USD | -138.332% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 54.536% |
| Avitar, Inc. | 836.7 Thousand USD | 4.439% |
| AVITA Medical, Inc. | 41.68 Million USD | 98.082% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 80056.2% |
| Össur hf. | 485.57 Million USD | 99.835% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 509.358% |
| QHSLab, Inc. | 793.6 Thousand USD | -0.75% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.835% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 95.225% |
| Escalon Medical Corp. | 5.14 Million USD | 84.463% |
| Aurora Spine Corporation | 8.21 Million USD | 90.263% |
| BrainsWay Ltd. | 23.09 Million USD | 96.537% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | -660.741% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 97.721% |
| Vivos Inc. | -6036.00 USD | 13346.554% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.85% |
| Kelyniam Global, Inc. | 2.03 Million USD | 60.73% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 205.659% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -1312.803% |
| Nanomix Corporation | -69.45 Thousand USD | 1251.145% |
| Theraclion SA | -1.08 Million USD | 174.007% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -36.084% |
| Positron Corporation | -353.46 Thousand USD | 326.207% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 23.524% |
| Lombard Medical, Inc. | 955 Thousand USD | 16.276% |
| ALR Technologies Inc. | 4945.00 USD | -16069.1% |
| Stratec SE | 71.58 Million USD | 98.883% |
| Vycor Medical, Inc. | 1.31 Million USD | 39.227% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 6298.155% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -287.349% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 94.433% |
| VMS Rehab Systems, Inc. | -10.44 USD | 7658739.847% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -2121.006% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -197.702% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 10094.525% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 26.917% |
| Urologix, Inc. | 6.09 Million USD | 86.877% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 352.474% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -12.07% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.98% |
| NIOX Group Plc | 28.13 Million USD | 97.158% |
| Fuse Medical, Inc. | 10.73 Million USD | 92.551% |
| Broncus Holding Corporation | 7.22 Million USD | 88.936% |
| Brain Scientific Inc. | 54.32 Thousand USD | -1371.812% |
| Health Logic Interactive Inc. | - USD | -Infinity% |